Market Tracker

07/30 3:57am ET

Depomed Inc (NASDAQ:DEPO)

31.87
Delayed Data
As of Jul 29
 -1.02 / -3.10%
Today’s Change
9.85
Today|||52-Week Range
33.74
+97.83%
Year-to-Date

Today’s Trading

Previous close32.89
Today’s open32.88
Day’s range31.67 - 33.09
Volume1,680,850
Average volume (3 months)2,085,532
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)+5.77%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio20.7
Price/Sales2.74
Price/Book5.35

Competitors

 Today’s
change
Today’s
% change
DNAIProNAi Therapeutics ...-0.73-2.72%
VBLTVascular Biogenics L...+0.08+1.35%
NEPTNeptune Technologies...-0.02-1.42%
TEVATeva Pharmaceutical-0.53-0.74%
Data as of 07/29/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts